ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 61 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,520,000 | -6.2% | 1,500,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,621,000 | -12.8% | 1,500,000 | -16.7% | 0.00% | 0.0% |
Q3 2020 | $1,860,000 | -6.3% | 1,800,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,985,000 | +8.9% | 1,800,000 | 0.0% | 0.00% | -50.0% |
Q1 2020 | $1,822,000 | -26.8% | 1,800,000 | -17.2% | 0.00% | 0.0% |
Q4 2019 | $2,488,000 | -44.4% | 2,175,000 | -44.6% | 0.00% | -50.0% |
Q3 2019 | $4,477,000 | +10.5% | 3,925,000 | +14.6% | 0.00% | 0.0% |
Q2 2019 | $4,051,000 | -29.5% | 3,425,000 | -19.4% | 0.00% | -20.0% |
Q1 2019 | $5,745,000 | +114.8% | 4,250,000 | +70.0% | 0.01% | +66.7% |
Q4 2018 | $2,675,000 | +15.8% | 2,500,000 | +13.6% | 0.00% | +50.0% |
Q3 2018 | $2,310,000 | +6.9% | 2,200,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $2,161,000 | -66.9% | 2,200,000 | -66.7% | 0.00% | -66.7% |
Q1 2018 | $6,520,000 | -18.4% | 6,600,000 | -12.8% | 0.01% | -14.3% |
Q4 2017 | $7,992,000 | +82.8% | 7,570,000 | +82.9% | 0.01% | +75.0% |
Q3 2017 | $4,373,000 | +19.4% | 4,140,000 | +19.8% | 0.00% | 0.0% |
Q2 2017 | $3,664,000 | +62.1% | 3,455,000 | +47.1% | 0.00% | +100.0% |
Q1 2017 | $2,261,000 | +103.9% | 2,348,000 | +113.5% | 0.00% | +100.0% |
Q4 2016 | $1,109,000 | -91.3% | 1,100,000 | -91.9% | 0.00% | -91.7% |
Q3 2016 | $12,685,000 | +797.1% | 13,630,000 | +581.5% | 0.01% | +500.0% |
Q2 2016 | $1,414,000 | -22.3% | 2,000,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $1,820,000 | -81.5% | 2,000,000 | -77.1% | 0.00% | -81.8% |
Q4 2015 | $9,813,000 | – | 8,723,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|